This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its chiral structure makes it valuable for the development of enantioselective drugs, particularly those targeting neurological disorders and inflammatory diseases. The trifluoromethyl group enhances the compound's metabolic stability and bioavailability, making it a preferred choice in drug design. Additionally, it serves as a building block in the creation of complex organic frameworks for research in asymmetric catalysis, enabling the production of high-purity chiral compounds for pharmaceutical applications.